Sign inJoin waitlistJoin the waitlist

Christopher Slapak

Adjunct Clinical Associate Professor of Medicine · Indiana University School of Medicine

Credentials: · ·

History

Indiana University School of Medicine
Present

Research

Clinical development of galunisertib (LY2157299 monohydrate), a small molecule inhibitor of transforming growth factor-beta signaling pathway
Review · Drug Designing Open Access · 2015 · 537 citations
An increase in the expression of ribonucleotide reductase large subunit 1 is associated with gemcitabine resistance in non-small cell lung cancer cell lines
Cancer Research · 2004 · Last of 6 authors · 246 citations
Phase II study of enzastaurin, a protein kinase C beta inhibitor, in patients with relapsed or refractory diffuse large B-cell lymphoma
Journal of Clinical Oncology · 2007 · 207 citations

SL
Stuart Levy
7 papers
DK
Donald Kufe
5 papers
Deborah Toppmeyer
3 papers
PF
Paula Fracasso
3 papers
Sven de Vos
3 papers
AF
Andres Forero-Torres
2 papers
BP
Brad Pohlman
2 papers
BL
Brian Link
2 papers
CR
Carol Richman
2 papers
FC
Francis Cummings
2 papers
JW
James Wooldridge
2 papers
JC
Jeffrey Clark
2 papers